Last reviewed · How we verify
NCT06683716: EmeRald
SmartGlass-Guided ERCP with Cannulation of Native Papilla 1.0
NA trial testing Training in presence of the instructor in Biliary Tract Diseases in 170 participants. Not yet recruiting.
1 June 2026
Quick facts
| Lead sponsor | Helios Kliniken Schwerin |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 170 |
| Start date | 2 January 2025 |
| Primary completion | 1 June 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Training in presence of the instructor
- Telemedically training by an instructor
Conditions studied
- Biliary Tract Diseases — all drugs for Biliary Tract Diseases →
- Pancreatic Diseases — all drugs for Pancreatic Diseases →
Sponsor
Helios Kliniken Schwerin
Who can join
18 and older, any sex, with Biliary Tract Diseases or Pancreatic Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this prospective randomized study is to evaluate whether telemedical assistance via SmartGlasses is equivalent to physical presence in teaching Endoscopic Retrograde Cholangiopancreaticography (ERCP) in terms of examination success and safety. Endoscopic papilla cannulation is a key skill for successful ERCP and therefore a measurable primary endpoint of the study. This can be measured as the time (in seconds/minutes) between stable visualization of the papilla and successful endoscopic cannulation of the target structure (bile duct or pancreatic duct).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06683716
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Biliary Tract Diseases
Currently open trials in the same condition.
- NCT06197984 — Antimicrobial Resistance in Acute Cholangitis · recruiting
- NCT06026449 — Gluten-free Diet in PSC and IBD · NA · active not recruiting
Other Helios Kliniken Schwerin trials
Trials by the same sponsor.
- NCT07007598 — Prevention of Post-Polypectomy Colorectal Bleeding by Clips in Patients on Anticoagulants · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06683716 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Helios Kliniken Schwerin
- Last refreshed: 12 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06683716.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing